Deya Alkhatib, MD
Cardiovascular Disease · Naples, FLNPI 1942725544
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 46.9% of the total. 2025 is the largest year on record at $2,761, more than ten times the $170 reported in 2020.
Across 62 payments — averaging $110.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$1K
- E.r. Squibb & Sons, L.L.C.$375
- Medtronic$306
- Nuwellis, Inc.$267
- AstraZeneca$170
- plus $1K from 12 others
What the payments were for
- Grants$1,39820%
- Travel & lodging$2,52137%
- Food & beverage$2,86442%
- Education$751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $3,217 |
| Boston Scientific | 4 | $1,457 |
| E.r. Squibb & Sons, L.L.C. | 10 | $375 |
| Medtronic | 3 | $306 |
| Nuwellis, Inc. | 1 | $267 |
| AstraZeneca | 2 | $170 |
| Edwards Lifesciences | 1 | $167 |
| Stryker | 1 | $126 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Penumbra, Inc. | 1 | $120 |
| Heartflow, Inc. | 1 | $111 |
| NS Pharma, Inc. | 1 | $110 |
| Pfizer | 5 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $86 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| Novartis | 1 | $27 |
| Recor Medical Inc | 1 | $25 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$1,541
- MitraClip$1,106
- AQUADEX SMARTFLOW CONSOLE$267
- AZURE XT DR MRI SURESCAN$239
- PASCAL$167
- FlowTriever$126
- AMVUTTRA$125
- Indigo System$120
- CAMZYOS$117
- AMPLATZER AMULET$114
- FFRct$111
- VILTEPSO$110
How this compares
$6,858 in reported general payments places this provider in the 70th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Naples
- William OneillNaples$637K
- Dee Dee WangNaples$173K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.